XGN Earnings

XGN reported its earnings on 2026-03-10, showcasing a revenue of 16.63M against an estimate of 16.37M, resulting in a 1.59% surprise. The EPS was -0.2, surpassing the expected -0.2 by 0%. The stock experienced a -3.85% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following XGN's earnings announcement on 2026-03-10, the stock price moved by -3.85% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, XGN's stock price tends to shift by an average of -4.59% in the 10 days leading up to earnings and 3.95% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate XGN's annual revenue to reach 17.26M, while the EPS is projected at -0.19. These estimates reflect recent revisions, with revenue estimates revised downward by -0.07% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between XGN's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised downward by -0.07%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, XGN's stock price typically moves by -4.59% in the 10 days before its earnings and 3.95% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of -0.19 and revenue of 17.26M.

The earnings call presents a mixed outlook. While there is strong volume growth and positive trends in market expansion, the delay in profitability targets and ASP challenges weigh negatively. The Q&A reveals management's cautious stance on profitability timelines and ASP, which adds uncertainty. However, the company's strategic investments and potential ASP improvements, alongside strong relationships with ACR, provide a balance. Without market cap data, a neutral prediction (-2% to 2%) is reasonable, reflecting both positive growth aspects and financial uncertainties.